4//SEC Filing
LEA LEIV 4
Accession 0001610717-25-000409
CIK 0001626971other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:21 PM ET
Size
5.3 KB
Accession
0001610717-25-000409
Insider Transaction Report
Form 4
LEA LEIV
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-04+400,000→ 400,000 totalExercise: $8.81Exp: 2035-12-04→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0000939012
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:21 PM ET
- Size
- 5.3 KB